Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Bliss GVS Pharma Ltd Pharmaceuticals - Indian - Formulations
 BSE Code
 506197
ISIN Demat
INE416D01022
Book Value
93.382807
Mar.Cap(Rs.Cr)
1,295.03
P/E
18.97
Face Value
1
Go
Your are on :   Markets   |  Company Profile   |  Profit And Loss
ParticularsMar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
Mar 2019
(Rs.Cr)
Mar 2018
(Rs.Cr)
INCOME :      
Sales Turnover 598.34636.36465.51441.95426.59298.29
Excise Duty0.000.000.000.000.000.40
Net Sales598.34636.36465.51441.95426.59297.89
Other Income 50.7735.3717.6837.0035.8111.00
Stock Adjustments -21.248.908.85-2.373.684.09
Total Income627.87680.63492.04476.58466.08312.98
EXPENDITURE :      
Raw Materials 293.66352.84262.15234.36228.83149.90
Power & Fuel Cost5.807.096.994.703.572.59
Employee Cost 72.5465.0658.6144.0233.8526.29
Other Manufacturing Expenses 11.5711.547.496.236.496.18
Selling & Administrative Expenses 66.9067.0736.9036.2343.9324.21
Miscellaneous Expenses 36.4832.4510.7613.8820.514.35
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure486.95536.05382.90339.42337.17213.52
Operating Profit140.93144.57109.14137.16128.9199.46
Interest 10.064.324.196.623.156.95
Gross Profit130.87140.25104.95130.54125.7692.51
Depreciation15.1713.8513.768.835.755.67
Profit Before Tax115.70126.4091.19121.71120.0186.84
Tax34.4231.9221.5231.8145.4430.20
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-4.211.812.16-2.440.14-0.38
Reported Net Profit85.4892.6667.5092.3374.4357.01
Extraordinary Items 0.262.09-0.020.53-1.470.72
Adjusted Net Profit85.2290.5767.5291.8075.9056.29
Adjustment below Net Profit -0.670.300.52-0.26-0.17-1.23
P & L Balance brought forward765.33676.22613.36533.69471.84422.21
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 3.973.865.1612.4112.416.19
P & L Balance carried down846.18765.33676.22613.36533.69471.80
Dividend0.000.000.000.000.0010.31
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %50.0050.0050.0050.00100.00100.00
Dividend Per Share(Rs)0.500.500.500.501.001.00
Earnings Per Share-Unit Curr8.218.946.548.957.225.53
Earnings Per Share(Adj)-Unit Curr8.218.946.548.957.225.53
Book Value-Unit Curr89.9682.1273.2666.2158.4952.49
Book Value(Adj)-Unit Curr89.9682.1273.2666.2158.4952.49
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)